Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil.

× No keyword cloud information.

21 in total

1. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.

Authors: Scott W Grimm; Neil M Richtand; Helen R Winter; Karen R Stams; Stots B Reele
Journal: Br J Clin Pharmacol Date: 2006-01 Impact factor: 4.335

2. The intestinal first-pass metabolism of substrates of CYP3A4 and P-glycoprotein-quantitative analysis based on information from the literature.

Authors: Motohiro Kato; Koji Chiba; Akihiro Hisaka; Michi Ishigami; Makoto Kayama; Naomi Mizuno; Yoshinori Nagata; Susumu Takakuwa; Yuko Tsukamoto; Kaoru Ueda; Hiroyuki Kusuhara; Kiyomi Ito; Yuichi Sugiyama
Journal: Drug Metab Pharmacokinet Date: 2003 Impact factor: 3.614

3. Validation of the hepatic blood flow rate model for verapamil first-pass metabolism.

Authors: Jovan Popović
Journal: Eur J Drug Metab Pharmacokinet Date: 2007 Jan-Mar Impact factor: 2.441

Review 4. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors: Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal: Adv Drug Deliv Rev Date: 2007-11-28 Impact factor: 15.470

Review 5. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.

Authors: Pertti J Neuvonen; Mikko Niemi; Janne T Backman
Journal: Clin Pharmacol Ther Date: 2006-12 Impact factor: 6.875

6. Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro.

Authors: Elke S Perloff; Su X Duan; Paul R Skolnik; David J Greenblatt; Lisa L von Moltke
Journal: Drug Metab Dispos Date: 2005-03-11 Impact factor: 3.922

7. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4.

Authors: J H Hochman; M Chiba; J Nishime; M Yamazaki; J H Lin
Journal: J Pharmacol Exp Ther Date: 2000-01 Impact factor: 4.030

Review 8. Lessons learned from the irinotecan metabolic pathway.

Authors: M K Ma; H L McLeod
Journal: Curr Med Chem Date: 2003-01 Impact factor: 4.530

9. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.

Authors: Amy S Etheridge; Sherry R Black; Purvi R Patel; James So; James M Mathews
Journal: Planta Med Date: 2007-07-05 Impact factor: 3.352

Review 10. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data.

Authors: L Z Benet; C L Cummins; C Y Wu
Journal: Curr Drug Metab Date: 2003-10 Impact factor: 3.731

2 in total

1. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.

Authors: Deep Kwatra; Balasubramanyam Budda; Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Dhananjay Pal; Ashim K Mitra
Journal: Mol Pharm Date: 2012-06-19 Impact factor: 4.939

2. Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism.

Authors: Hua Xing; Xiao Luo; Yang Li; Chunni Fan; Ning Liu; Chunguo Cui; Wenjia Li
Journal: Pharm Biol Date: 2020-12 Impact factor: 3.503

2 in total